Back to Search
Start Over
358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS394-S394. 1p. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152695043
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.460